Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice

Respiratory Research

Volumn 8, Issue , 2007, Pages

  van der Deen, Margaretha ^a   Timens, Wim ^a   Timmer Bosscha, Hetty ^a   van der Strate, Barry W ^a   Scheper, Rik J ^b   Postma, Dirkje S ^a   de Vries, Elisabeth G ^a   Kerstjens, Huib A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; P GLYCOPROTEIN 2; P-GLYCOPROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; EMPHYSEMA; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; SMOKE; SMOKING;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; EMPHYSEMA; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; LUNG; MALE; MICE; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; SMOKING;

EID: 34848872515     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-49     Document Type: Article

References (31)

1. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258:1650-1654. 10.1126/science.1360704, 1360704.
2. Balayssac D, Authier N, Cayre A, Coudore F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicol Lett 2005, 156:319-329. 10.1016/j.toxlet.2004.12.008, 15763631.
3. Brechot JM, Hurbain I, Fajac A, Daty N, Bernaudin JF. Different pattern of MRP localization in ciliated and basal cells from human bronchial epithelium. J Histochem Cytochem 1998, 46:513-517.
4. Scheffer GL, Pijnenborg AC, Smit EF, Muller M, Postma DS, Timens W, van der Valk P, de Vries EG, Scheper RJ. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002, 55:332-339. 1769658, 11986335.
5. van der Deen M, de Vries EG, Timens W, Scheper RJ, Timmer-Bosscha H, Postma DS. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 2005, 6:59. 1200430, 15967026, 10.1186/1465-9921-6-59.
6. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 2001, 276:27846-27854. 10.1074/jbc.M102453200, 11375986.
7. Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 1997, 57:5238-5242.
8. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997, 94:4028-4033. 20562, 9108099, 10.1073/pnas.94.8.4028.
9. Johnson DR, Finch RA, Lin ZP, Zeiss CJ, Sartorelli AC. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Res 2001, 61:1469-1476.
10. Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, Mayer U, Beijnen JH, van der Valk M, Krimpenfort P, Borst P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 1997, 3:1275-1279. 10.1038/nm1197-1275, 9359705.
11. Leier I, Jedlitschky G, Buchholz U, Keppler D. Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells. Eur J Biochem 1994, 220:599-606. 10.1111/j.1432-1033.1994.tb18661.x, 8125120.
12. van der deen M, Marks H, Willemse BW, Postma DS, Muller M, Smit EF, Scheffer GL, Scheper RJ, de Vries EG, Timens W. Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients. Virchows Arch 2006, 449:682-688. 10.1007/s00428-006-0240-3, 17072643.
13. Wijnholds J, de Lange EC, Scheffer GL, van den Berg DJ, Mol CA, van der Valk M, Schinkel AH, Scheper RJ, Breimer DD, Borst P. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest 2000, 105:279-285. 377447, 10675353.
14. Griffith RB, Hancock R. Simultaneous mainstream-sidestream smoke exposure systems I. Equipment and procedures. Toxicology 1985, 34:123-138. 10.1016/0300-483X(85)90162-3, 3969685.
15. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HA. Cigarette Smoke-induced Emphysema: A Role for the B Cell?. Am J Respir Crit Care Med 2006, 173:751-758. 10.1164/rccm.200504-594OC, 16399994.
16. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967, 95:752-764.
17. Schultz MJ, Wijnholds J, Peppelenbosch MP, Vervoordeldonk MJ, Speelman P, van Deventer SJ, Borst P, van der Poll T. Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J Immunol 2001, 166:4059-4064.
18. Verbon A, Leemans JC, Weijer S, Florquin S, van der Poll T. Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis. Clin Exp Immunol 2002, 130:32-36. 10.1046/j.1365-2249.2002.01952.x, 12296850, 1906484.
19. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000, 103:757-768. 10.1016/S0092-8674(00)00179-3, 11114332.
20. van de Ven R, de Jong MC, Reurs AW, Schoonderwoerd AJ, Jansen G, Hooijberg JH, Scheffer GL, de Gruijl TD, Scheper RJ. Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J Immunol 2006, 176:5191-5198.
21. Xu D, Regner M, Smith D, Ruby J, Johnstone R, Mullbacher A. The multidrug resistance gene mdr1a influences resistance to ectromelia virus infection by mechanisms other than conventional immunity. Immunol Cell Biol 2004, 82:462-470. 10.1111/j.0818-9641.2004.01274.x, 15479431.
22. Pease JE, Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med 2002, 1:19-25.
23. de Boer WI. Cytokines and therapy in COPD: a promising combination?. Chest 2002, 121:209S-218S. 10.1378/chest.121.5_suppl.209S, 12010854.
24. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S, Suzuki T, Sasaki H. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 2004, 556:249-252. 10.1016/S0014-5793(03)01399-1, 14706858.
25. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005, 26:835-845. 10.1183/09031936.05.00108904, 16264044.
26. Hayashi A, Suzuki H, Itoh K, Yamamoto M, Sugiyama Y. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 2003, 310:824-829. 10.1016/j.bbrc.2003.09.086, 14550278.
27. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004, 114:1248-1259. 524225, 15520857, 10.1172/JCI200421146.
28. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
29. D'hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir Res 2005, 6:147. 1334210, 16359546, 10.1186/1465-9921-6-147.
30. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004, 170:974-980. 10.1164/rccm.200309-1270OC, 15282203.
31. Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP. Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L931-L945. 10.1152/ajplung.00201.2005, 16361358.